Keywords
How to Cite
Abstract
:Polikistik tuxumdon sindromi reproduktiv yoshdagi ayollarda eng ko‘p uchraydigan endokrin va metabolik buzilishlardan biri bo‘lib, hayz siklining buzilishi, giperandrogenizm, ovulyatsiya yetishmovchiligi, bepushtlik, semirish, insulin rezistentligi va uzoq muddatli kardiometabolik xavf bilan tavsiflanadi
References
1. Teede H.J., Tay C.T., Laven J.J.E. va boshqalar. Recommendations from the 2023 International Evidence based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology and Metabolism. 2023. 2. Monash University. International Evidence based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Guideline and technical resources. 2023. 3. American College of Obstetricians and Gynecologists. Polycystic Ovary Syndrome. Practice Bulletin. 2018. 4. MSD Manual Professional Edition. Polycystic Ovary Syndrome. Gynecology and Obstetrics section. Revised 2025. 5. American Society for Reproductive Medicine. Recommendations from the
2023 International Evidence based Guideline for PCOS. 2023. 6. Balen A.H., Morley L.C., Misso M. va boshqalar. The management of
anovulatory infertility in women with PCOS. Reproductive medicine reviews. 7. Legro R.S., Arslanian S.A., Ehrmann D.A. va boshqalar. Diagnosis and treatment of polycystic ovary syndrome. Endocrine review
8. Goodman N.F., Cobin R.H., Futterweit W. va boshqalar. American
Association of Clinical Endocrinologists guidelines for PCOS. Endocrine Practice. 9. International PCOS Network resourcesfor health professionals. Diagnostic algorithm and patient centred management materials. 2024. 10. Pinkerton J.V. Polycystic Ovary Syndrome. Clinical overview for differential diagnosis and treatment selection. 2025
This work is licensed under a Creative Commons Attribution 4.0 International License.
